{"id":"W3157319772","doi":"10.1136/annrheumdis-2020-219717","title":"Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"Celgene; Gilead Sciences; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Ixekizumab; Placebo; Clinical endpoint; Internal medicine; Ankylosing spondylitis; Clinical trial; Disease; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004400023,0.001236989,0.003333944,0.0003661704,0.0004384686,0.0007363142,0.0008359434,0.001748602,0.003510119],"category_scores_gemma":[0.003622324,0.0005995236,0.002183148,0.0003837287,0.00151186,0.001129492,0.0004285901,0.002510183,0.000461697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005564346,"about_ca_system_score_gemma":0.001301583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005762642,"about_ca_topic_score_gemma":0.001228811,"domain_scores_codex":[0.9982128,0.001048476,0.0002146187,0.0002297544,0.0001418228,0.000152518],"domain_scores_gemma":[0.9970136,0.001070566,0.0008084243,0.0002677389,0.0002133076,0.0006263584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9655741,0.00821932,0.0009332381,0.0005928903,0.0005948496,0.00003673976,0.00008914256,0.0001443127,0.004867016,0.00003375181,0.0002715312,0.01864308],"study_design_scores_gemma":[0.7830293,0.2135921,0.002121024,0.00002793673,0.0003212387,0.00004349718,0.00002073337,0.0001513696,0.00040943,0.00003607453,0.0002359165,0.00001141064],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942089,0.002854487,0.0003658806,0.0002224927,0.0001480535,0.00149298,0.0003339158,0.00003558841,0.0003376239],"genre_scores_gemma":[0.990729,0.002546779,0.001527465,0.0006017231,0.0004484629,0.002424543,0.0006422158,0.00001990503,0.001060006],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004400023,"threshold_uncertainty_score":0.02326983,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01644860238706701,"score_gpt":0.2678222205081061,"score_spread":0.251373618121039,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}